Cancer Research Meeting Calendar  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 47, 5919-5923, November 15, 1987]
© 1987 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beck, S. A.
Right arrow Articles by Tisdale, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beck, S. A.
Right arrow Articles by Tisdale, M. J.

Production of Lipolytic and Proteolytic Factors by a Murine Tumor-producing Cachexia in the Host1

Susan A. Beck2 and Michael J. Tisdale

CRC Experimental Chemotherapy Group, Pharmaceutical Sciences Institute, Aston University, Birmingham B4 7ET, United Kingdom

Animals given transplants of the MAC16 colon adenocarcinoma show a progressive decrease in carcass weight as the tumor size increases without a reduction in either fluid or caloric intake when compared with non-tumor-bearing controls. There is a decrease in both carcass fat and muscle mass which is directly proportional to the weight of the tumor. In male animals weight loss occurs when the tumor mass comprises more than 0.3% of the body weight and reaches 30% when the tumor represents 3% of the body weight.

There is evidence for the production by the tumor of both lipolytic and proteolytic factors, which may be responsible for the cachexia, since two related mouse adenocarcinomas, which do not produce weight loss, have little lipolytic or proteolytic activity. The lipolytic factor is nondialyzable and is destroyed by both heat and acid. Both insulin and 3-hydroxybutyrate suppress the lipolytic activity of the tumor extract. The MAC16 tumor also contains a serine protease, the activity of which is also completely abolished by insulin and 3-hydroxybutyrate. Animals bearing the MAC16 tumor have an elevated plasma lipolytic and proteolytic activity when compared with non-tumor-bearing controls, suggesting a peripheral effect of the tumor products. The catabolic factors elaborated by the MAC16 adenocarcinoma may be responsible for the loss of both the fat and nonfat carcass mass, but they do respond to normal metabolic controls.

1 This work has been supported by a grant from the Cancer Research Campaign.

2 Recipient of a research studentship from the Cancer Research Campaign.

Received 4/10/87. Revised 8/ 6/87. Accepted 8/13/87.




This article has been cited by other articles:


Home page
Cancer Res.Home page
P. T. Todorov, S. M. Wyke, and M. J. Tisdale
Identification and Characterization of a Membrane Receptor for Proteolysis-Inducing Factor on Skeletal Muscle
Cancer Res., December 1, 2007; 67(23): 11419 - 11427.
[Abstract] [Full Text] [PDF]


Home page
Nutr Clin PractHome page
R. Siddiqui, D. Pandya, K. Harvey, and G. P. Zaloga
Nutrition Modulation of Cachexia/Proteolysis
Nutr Clin Pract, April 1, 2006; 21(2): 155 - 167.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. L. Monitto, S.-M. Dong, J. Jen, and D. Sidransky
Characterization of a Human Homologue of Proteolysis-Inducing Factor and Its Role in Cancer Cachexia
Clin. Cancer Res., September 1, 2004; 10(17): 5862 - 5869.
[Abstract] [Full Text] [PDF]


Home page
Biol Res NursHome page
D. O. McCarthy
Rethinking Nutritional Support for Persons with Cancer Cachexia
Biol Res Nurs, July 1, 2003; 5(1): 3 - 17.
[Abstract] [PDF]


Home page
Cancer Res.Home page
A. S. Whitehouse, H. J. Smith, J. L. Drake, and M. J. Tisdale
Mechanism of Attenuation of Skeletal Muscle Protein Catabolism in Cancer Cachexia by Eicosapentaenoic Acid
Cancer Res., May 1, 2001; 61(9): 3604 - 3609.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
C. Bing, M. Brown, P. King, P. Collins, M. J. Tisdale, and G. Williams
Increased Gene Expression of Brown Fat Uncoupling Protein (UCP)1 and Skeletal Muscle UCP2 and UCP3 in MAC16-induced Cancer Cachexia
Cancer Res., May 1, 2000; 60(9): 2405 - 2410.
[Abstract] [Full Text]


Home page
Am. J. Clin. Nutr.Home page
S.-S. Yeh and M. W Schuster
Geriatric cachexia: the role of cytokines
Am. J. Clinical Nutrition, August 1, 1999; 70(2): 183 - 197.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. J. Tisdale
Wasting in Cancer
J. Nutr., January 1, 1999; 129(1): 243S - 243S.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Kuno, N. Kanada, E. Nakashima, F. Fujiki, F. Ichimura, and K. Matsushima
Molecular Cloning of a Gene Encoding a New Type of Metalloproteinase-disintegrin Family Protein with Thrombospondin Motifs as an Inflammation Associated Gene
J. Biol. Chem., January 3, 1997; 272(1): 556 - 562.
[Abstract] [Full Text] [PDF]


Home page
JPEN J Parenter Enteral NutrHome page
M. J. Mcnamara, H. R. Alexander, and J. A. Norton
Cytokines and Their Role in the Pathophysiology of Cancer Cachexia
JPEN J Parenter Enteral Nutr, November 1, 1992; 16(6_suppl): 50S - 55S.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1987 by the American Association for Cancer Research.